2.93 USD
▲+0.14+6.55%
盘后 2.75 +0.05%
2026-08-03
市值
$23.01M
市盈率
—
EPS
-6.05
股息率
—
52 周区间
2.50 – 12.24
成交量
242.37K
Beta
2.09
目标价
—
52W 低 2.5052W 高 12.24
价格走势
公司简介
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including ...